Research VEGF
Genentech Biooncology

Resources for this topic

multimedia callout footer

VEGF: a critical pro-angiogenic factor in breast cancer

Of 6 angiogenic factors analyzed by Relf et al, only VEGF significantly correlated with breast cancer relapse16

Of 6 angiogenic factors analyzed by Relf et al, only VEGF significantly correlated with breast cancer relapse
In a study by Relf et al, expression of VEGF significantly correlated with an increased risk of relapse. Of the 6 angiogenic factors studied by the investigators, only VEGF showed a significant correlation with relapse.16

Reprinted with permission of the American Association for Cancer Research. Relf M, LeJeune S, Scott PA, et al. Cancer Res. 1997;57:963-969.

In a series of elegant experiments, Relf and colleagues isolated angiogenic factors from 64 primary breast tumors and investigated the relationship of these factors to tumor growth and progression. These factors included vascular endothelial growth factor (VEGF), transforming growth factor-β1 (TGF-β1), pleiotrophin, acidic and basic fibroblast growth factor (FGF), and platelet-derived endothelial cell growth factor. Overall, they showed that VEGF is one of the most important mediators of tumor angiogenesis in human breast cancer tissue and that elevated VEGF levels correlated with poor survival. Importantly, Relf et al also showed that, of all the angiogenic factors studied, VEGF was the only factor linked to poor relapse-free survival.16

Next section

VEGF expressed throughout the tumor life cycle

View references
for this site section